approved glp 1 agonists List of and pending GLP-1 medications Overview of structure, date of
Description
Retatrutide activates GIPR and GCGR , achieving over 20% weight loss in phase 2 trials

[DOI] [PubMed] [Google Scholar] 39.Brunton SA, Wysham CH

10.1016/j.molmet.2020.101102 59 NeelandI

That study will provide insights into the potential of GLP-1 RAs to modify the disease course in HFpEF patients

muciniphila had better success colonizing with A

Abstract Purpose of Review The purpose of this review is two-fold: (1) to discuss a case report of idiopathic intracranial hypertension (IIH) after abrupt cessation of a glucagon-like peptide-1 (GLP-1) receptor agonist with resultant rapid weight gain and (2) to review the literature regarding the potential role of GLP-1 receptor agonists in the treatment of IIH as well as potential pitfalls
